Epidemiology of pancreatic cancer in Connecticut.
D000230:Adenocarcinoma / Q000453:epidemiology; D000328:Adult; D000367:Age Factors; D000368:Aged; D044383:Black People; D002277:Carcinoma / Q000453:epidemiology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000453:epidemiology; D003237:Connecticut; D003536:Cystadenocarcinoma / Q000453:epidemiology; D003609:Dactinomycin / Q000627:therapeutic use; D005191:Family Characteristics; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery; D011379:Prognosis; D012067:Religion; D012111:Residence Characteristics; D012621:Seasons; D012737:Sex Factors; D013852:Thiotepa / Q000627:therapeutic use; D044465:White People; D001741:Black or African American
D009588:Nitrogen Mustard Compounds; D003609:Dactinomycin; D013852:Thiotepa